CHR Publications

Peer Reviewed

  1. Walker I. Survey of the Canadian Hemophilia Population. Can J Public Health 82:127-129, March/April 1991.

  2. Canadian Hemophilia Clinic Directors Group. Effect of using safer blood products on prevalence of HIV infection in haemophilic Canadians. Brit Med J 306: 306-7, 1993.

  3. Blanchette V, Walker I, Gill P, Adams M, Roberts R, Inwood M, Canadian Hemophilia Clinic Directors Group. Hepatitis C Infection in Patients with Hemophilia. Results of a National Survey. Transfusion Medicine Reviews. 1994;8:210-217.

  4. Walker I et al. The Canadian Hemophilia Registry as the Basis for a National System for Monitoring the Use of Factor Concentrates. Transfusion 1995; 35:548-551

  5. Walker I, Julian J. Association of Hemophilia Clinic Directors of Canada. Causes of Death in Canadians with Hemophilia 1980-95. Hemophilia 1998; 4:704 713

  6. Arnold DM, Julian JA, Walker IR, for the Association of Hemophilia Clinic Directors of Canada. Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-up. Blood 108:460-464, 2006.

Associated Editorial to reference 4

Van Aken WG. The need for a national blood product monitoring system: role of hemophilia registries. Transfusion 1995; 35:540-541.

Meeting Abstracts

  1. Walker 1, Canadian Hemophilia Clinic Directors Group. Enumeration of the Canadian Hemophilia Population. XIX International Congress of The World Federation of Hemophilia 1990, Washington, DC. Book of Abstracts p.45, 1990.

  2. Walker IR, Canadian Hemophilia Clinic Directors Group. HIV in Canadians with Hemophilia: Prevalence, Mortality and the Impact of Safer Factor Concentrates. XX Congress of the World Federation of Hemophilia, Athens, Greece, October 1992.

  3. Blanchette VS, Walker 1, Inwood M, Adams M, Gill P and the Canadian Hemophilia Clinic Directors Group. Prevalence of Hepatitis C infection in individuals with Hemophilia: Results of a National Study. XX Congress of the World Federation of Hemophilia, Athens, Greece, October 1992.

  4. Walker IR, and the Canadian Hemophilia Clinical Directors Group. Canadian Hemophilia Registry (CHR) - Update and Assessment of Completeness. XXI International Congress of the World Federation of Hemophilia, Mexico City, Mexico. April 1994.

  5. Walker I, Association of Hemophilia Clinic Directors of Canada. Causes of Death in Canadians with Hemophilia 1980-93. National Hemophilia Foundation Conference. Liver Disease in Hemophilia: New Directions in Diagnosis, Management and Treatment. Atlanta, Georgia, March 3-5, 1995.

  6. Walker I, Julian J. Causes of Death in Canadians with Hemophilia. XXII International Congress of the World Federation of Hemophilia, Dublin, Ireland. 1996

  7. Walker I, Julian J, AHCDC, CANHC. Canadian Hemophilia Registry - HIV, HCV and mortality. XXIV Int. Congress of the World Federation of Hemophilia, Montreal, Canada, July 2000.

  8. Walker I, Julian J, AHCDC, CANHC. Decreasing Death Rate from HIV Infection, World Federation of Hemophilia, Seville, Spain, May 2002.

  9. Walker I, Webert K et al. Prevalence of Inhibitors in the Canadian Hemophilia Population. World Federation of Hemophilia XXVIII Int. Congress, Istanbul, Turkey, June, 2008. Haemophilia 2008;14 (suppl 2):56


Visitors since
June 2003:


Dr. Irwin Walker, Director
walkeri@mcmaster.ca

Site Design by: Biro Creative